United States - English - NLM (National Library of Medicine)

crossj - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - purpose: skin brightening, anti wrinkle uses:  the core ingredient of xoul, human adipose stromal cell conditioned media, peptide composition and dawnergy provide immediate calming and nourishment to damaged skin.

United States - English - NLM (National Library of Medicine)

crossj - diethylamino hydroxybenzoyl hexyl benzoate (unii: anq870jd20) (diethylamino hydroxybenzoyl hexyl benzoate - unii:anq870jd20), ethylhexyl triazone (unii: xqn8r9sak4) (ethylhexyl triazone - unii:xqn8r9sak4) - purpose: sunscreen uses:  xoul 60 days sun cream complements sun cream’s weakness, which weakens uv protection effects after opening product. protect your skin with fresh suncream every time!

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ims vet pty ltd - cross-linked polyacrylamide hydrogel - unknown - cross-linked polyacrylamide hydrogel solvent-water active 0.0 - active constituent

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

cross-linked sodium hyaluronate -

Australia - English - Department of Health (Therapeutic Goods Administration)

adler ortho australia pty ltd - 35661 - acetabulum prosthesis - the cross-linked pe/pe insert is fitted into the acetabular cup (acetabular shell) and is blocked inside the cup through a locking system present of the acetabular cup in the same group size with which the insert is coupled (i.e. equatorial teeth). it is available in different internal diameters and it articulates with the ceramic femoral head or the co-cr femoral head of the same internal diameter of the insert, permitting to restore the physiological motion of the hip joint. the cross-linked pe/pe insert is designed to be used in total hip arthroplasty (tha), as an articulating surface, and to interface with a ceramic femoral head or a co-cr femoral head, after insertion into an acetabulum prosthesis shell (acetabular cup).

Australia - English - Department of Health (Therapeutic Goods Administration)

perios pty ltd - 43167 - acetabular shell - a cross-linked polyethylene insert designed to reduce ware and as a result retard the onset of osteolysis. the device should be used only with an alumina head or a cocr metal head but not with a stainless steel head. the insert a component of the atlas system is intended for primary, dysplasic or protruding coxarthrosis; rheumatoid coxitis; coxarthrosis with necrosis of the femoral head; revision surgery in a septic or aseptic environment; congenital dislocation; traumatic injuries; femoral neck fracture and osteonecrosis of the femoral head.

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-excel australia pty ltd - 17521 - catheter, angioplasty, balloon dilatation, coronary perfusing - the catheter's dilating element is a balloon near the distal tip. the balloon centre has one or two radiopaque marker band and two visual markers proximal on the shaft which has a distal port. the guidewire lumen begins at the distal port end ends at distal tip. a hub at the proximal end of the catheters is for balloon inflation by injecting contrast medium. the guidewire exits the lumen at the distal port and travels alongside the catheter shaft and hub for the proximal portion of the catheter. the across cto ptca catheters are indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.